The autophagy-related protein (ATG)-dependent pathway, sequestering cargo into autophagosomes that fuse with lysosomes, in which the cargo is degraded. Proteins, organelles (such as mitochondria) and invading microorganisms are selectively degraded by macroautophagy. Bulk cytoplasmic autophagy occurs as a starvation response. Abstract | Autophagy is a fundamental eukaryotic pathway that has multiple effects on immunity. Autophagy is induced by pattern recognition receptors and, through autophagic adaptors, it provides a mechanism for the elimination of intracellular microorganisms. Autophagy controls inflammation through regulatory interactions with innate immune signalling pathways, by removing endogenous inflammasome agonists and through effects on the secretion of immune mediators. Moreover, autophagy contributes to antigen presentation and to T cell homeostasis, and it affects T cell repertoires and polarization. Thus, as we discuss in this Review, autophagy has multitiered immunological functions that influence infection, inflammation and immunity.
1 and non-canonical autophagy 2 -that enable cells to digest their cytoplasmic contents in lysosomes. Macroautophagy, which is autophagy in its strictest form and which is the focus of this Review, depends on specialized autophagy-related proteins (ATGs) 1
and is distinct from other cytoplasmic digestive processes, including proteasomal degradation, as a result of its ability to capture and to eliminate large targets such as toxic protein aggregates, defunct or disused organelles and invading microorganisms. Several autophagy-related factors have also been recognized to have autophagy-independent immune functions 3 , but these are not discussed in this Review.
Autophagy may be the primordial form of eukaryotic innate immunity against invading microorganisms. Our understanding of the immunological functions of autophagy has dramatically increased in recent years 4 , and it is now appreciated that, in mammals, these primordial functions of autophagy have evolved and have been incorporated into multiple innate and adaptive immune pathways. In this Review, we discuss the four main roles of autophagy in immunity: the direct elimination of microorganisms, the control of inflammation, the control of adaptive immunity through the regulation of antigen presentation and lymphocyte homeostasis, and the secretion of immune mediators (FIG. 1) .
The autophagy pathway ATG-dependent autophagy. The principal morphological feature of autophagy is the formation of endomembranous organelles, which are known as autophagosomes
. An ensemble of ATG factors drives the formation in the cytoplasm of the autophagic isolation membrane (also known as the phagophore) 1 
. Beclin 1 (the mammalian orthologue of the yeast protein ATG-6), the serine/threonine protein kinase ULK1 (the mammalian paralogue of the yeast protein ATG-1), autophagyrelated LC3 proteins and γ-aminobutyric acid receptor-associated proteins (GABARAPs; the mammalian paralogues of the yeast ATG-8 protein) are key regulators of phagophore formation 1
. A phagophore, which is often depicted in models as an isolated crescent in the cytoplasm, is transiently connected to and derived from phosphatidylinositol-3-phosphate (PtdIns 3 P)-positive domains of the endoplasmic reticulum (ER), which are known as omegasomes 1 . Other cellular compartments, such as the Golgi apparatus, the mitochondria and the plasma membrane-derived endocytic organelles, also contribute to phagophore formation 1 . Recent studies suggest that the ER-derived autophagosomes form at ER-mitochondria contact sites 5 . A phagophore sequesters the captured cytoplasmic cargo that is destined for autophagic disposal and, following elongation and closure, an autophagosome is formed. At this stage, the corresponding endomembranes are commonly visualized as double membrane structures 1 . The degradation of the captured cargo begins when the double membrane autophagosome matures into a single
Microautophagy
Lysosomal import and degradation of small portions of the cytoplasm that is independent of autophagy-related proteins (ATGs), and that is often manifested as invaginations of the lysososomal membrane into the lysosomal lumen.
Chaperone-mediated autophagy
The import and degradation of soluble cytoplasmic proteins by chaperone-dependent direct translocation across the lysosomal membrane.
membrane-delimited autolysosome. Autophagosomal maturation is induced by the translocation of the SNARE protein syntaxin 17 (REF. 6) to the outer membrane of the completed autophagosome. This facilitates fusion of the autophagosome with lysosomes 5, 6 and results in the acidification of the autophagosome lumen, the acquisition of lysosomal hydrolases and the degradation of the cargo as well as the inner of the two membranes 1 .
Immune signalling and autophagy. A deficiency of intracellular nutrients because of competition from invading microorganisms is likely to have been one of the primordial danger signals that was available to eukaryotic cells to detect microbial invasion and to eliminate pathogens through autophagy. Consistent with this idea, metabolic signalling downstream of amino acid starvation has been associated with antimicrobial autophagy in response to bacterial 7 and viral infection 8 (FIG. 1a) . Metabolic regulation by mammalian target of rapamycin (mTOR), which inhibits autophagy, and AMP-activated protein kinase (AMPK), which activates autophagy, has been covered in detail elsewhere 1 .
The ancient defence mechanism of autophagy has been well integrated with other immune-sensing systems. Pattern recognition receptor (PRR) signalling that is induced following the recognition of pathogenassociated molecular patterns (PAMPs) and damageassociated molecular patterns (DAMPs) can activate autophagy
; for example, Toll-like receptor 4 (TLR4) signalling leads to ubiquitylation of the ATG beclin 1 by the E3 ligase TNF receptor-associated factor 6 (TRAF6) 9 . Ubiquitylated beclin 1 is released from its inhibitor B cell lymphoma 2 (BCL-2) and becomes active 9 . TRAF6 also activates ULK1 through ubiquitylation 10 and thereby controls both key pathways that lead to autophagy
. TRAF6, ubiquitylated ULK1 and the IκB kinase (IKK) regulators TAK1-binding protein 2 (TAB2) and TAB3 also have roles in starvation-induced autophagy (BOX 2) , which supports the idea that a similar circuitry, with some variations, becomes induced by nutritional and innate immune signals. In BOX 2,  we propose a model by which immune and nutritional triggers converge in common signalling pathways to activate autophagy.
Box 1 | The autophagy pathway
Autophagy is controlled by the regulatory serine/threonine protein kinases ULK1 and ULK2 (which are the mammalian homologues of the yeast autophagy-related protein 1 (ATG-1)) and by the lipid kinase activity of the class III phosphatidylinositol-3-phosphate kinase (PtdIns 3 K) VPS34 (VPS-34 in yeast), which forms a complex with beclin 1 (which is the mammalian orthologue of yeast ATG-6) and ATG14-like protein (ATG14L). ULK1, ULK2 and the VSP34-beclin 1-ATG14L complex integrate upstream signals. These factors, which are engaged in the activation of autophagy during nutritional and immune responses, induce the downstream ATG conjugation cascade 1 . This involves the association of the ATG5-ATG12 conjugate with ATG16L1. The ATG5-ATG12-ATG16L1 complex facilitates the addition of a phosphatidylethanolamine group to the carboxyl terminus of the mammalian paralogues of ATG-8: LC3A, LC3B (which has been used as a marker for the identification of autophagosomes in mammalian cells), LC3C, γ-aminobutyric acid receptor-associated protein (GABARAP), GABARAP-like 1 (GABARAPL1) and GABARAPL2 (REF. 1 ). Lipidated mammalian paralogues of ATG-8 function together with other factors to assemble, elongate and lead to the closure of nascent autophagic organelles 1 (see the figure) . The lipid kinase VPS34, through its production of PtdIns 3 phosphate (PtdIns 3 P), has a dual function in autophagy 1 . During initiation, VPS34-derived PtdIns 3 P is recognized by the PtdIns 3 P-binding factors WD repeat domain phosphoinositide-interacting protein 1 (WIPI1)-WIPI4 (which are the mammalian paralogues of yeast ATG-18), and these factors cooperate with ATG2 and ATG9 to form the phagophore 1 . During the final maturation of autophagosomes into autolysosomes, the attachment of a tail-anchored SNARE, syntaxin 17 (REF. 6 ), to the autophagosomal membrane enables fusion with lysosomes. At this stage, the VPS34-beclin 1 complex contains ultraviolet radiation resistance-associated gene protein (UVRAG) instead of ATG14L 1 . Autophagy requires the rapid remodelling of endomembranes in the cytoplasm, which involves the formation of transient PtdIns 3 P-positive structures (known as omegasomes) on the endoplasmic reticulum (ER), the ER-mitochondria contact sites, the Golgi apparatus and the plasma membrane-derived endosomal organelles. This happens independently of transcriptional changes. However, transcriptional adjustments are necessary for sustained autophagy, for instance, to replenish 'consumables' such as LC3 and autophagic adaptors including sequestosome 1 (also known as p62), which are degraded along with the captured cargo in autolysosomes. Transcriptional adjustments are accomplished by transcription-positive regulators (for example, transcription factor EB (TFEB), forkhead box protein O3A (FOXO3A) and NFE2-related factor 2 (NRF2)) and transcription-negative regulators (for example, zinc finger protein with KRAB and SCAN domains 3 (ZKSCAN3; also known as ZNF306), which coordinate autophagy with lysosomal, proteasomal, lipolytic and oxidative stress response systems 138, 139 . HOPS, homotypic fusion and vacuole protein sorting. DAMPs, such as DNA complexes 11 , ATP 12 and highmobility group box 1 protein (HMGB1) 13 , also activate autophagy. HMGB1 derepresses beclin 1 by displacing its negative regulator BCL-2
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, and can also extracellularly activate autophagy by interacting with its cell surface receptor RAGE (receptor for advanced glycation end products).
Inflammatory cytokines are also involved in the activation of autophagy
. Indeed, the induction of autophagy by the pro-inflammatory cytokine interleukin-1β (IL-1β) is crucial for the control of Mycobacterium tuberculosis in infected macrophages 14 . IL-1β signals through the IL-1 receptor (IL-1R) 14 and probably through the downstream recruitment of TRAF6 and the subsequent TRAF6-dependent ubiquitylation of beclin 1 (REF. 9). T helper 1 (T H 1) cell-derived cytokines, such as interferon-γ (IFNγ), also induce autophagy in effector cells; for example, these cytokines induce autophagy in macrophages to enable them to resist mycobacteria infection [15] [16] [17] . IFNγ might activate autophagy both through the function of immunityrelated GTPases [15] [16] [17] and through the phosphorylation of beclin 1 on Thr119 of its BH3 domain by deathassociated protein kinase 1 (DAPK1). This results in the dissociation of beclin 1 from its inhibitor BCL-2 (REF. 18 ) and, together with other processes
, leads to beclin 1 activation. In human macrophages, but not in mouse macrophages, IFNγ cooperates with 1,25-dihydroxyvitamin D3 (also known as calcitriol) to induce antimycobacterial autophagic activities 19 . Similarly, tumour necrosis factor (TNF) has been shown to stimulate autophagy to restrict intracellular bacteria such as Shigella spp. and Listeria spp 20 . By contrast, T H 2 cell-associated cytokines, such as IL-4 and IL-13, inhibit autophagy 16 . The signalling pathways that lead to the inhibition of autophagy by IL-4 and IL-13 are context dependent: they occur through AKT signalling when autophagy is induced by starvation, and are AKT independent and signal transducer and activator of transcription 6 (STAT6) dependent when autophagy is induced by IFNγ 16 . IL-10 can also inhibit autophagy through AKT signalling 21 . Moreover, STAT3, which transduces signals downstream of various signals including IL-6, can inhibit autophagy 22 . This inhibitory pathway does not involve transcriptional signalling, but instead involves the binding of cytoplasmic STAT3 to protein kinase R (PKR; also known as IFN-induced double-stranded RNA-activated protein kinase) 22 . STAT3 interacts through its SH2 domain with PKR and inhibits it. This prevents PKR from facilitating autophagy through the hyperphosphorylation of eukaryotic translation initiation factor 2α (EIF2α; also known as EIF2S1) and the subsequent inhibition of cellular and viral protein synthesis 22 . Reactive oxygen species (ROS) are classical antimicrobial effectors, which have an important role in immune signalling. ROS, and the oxidases that generate them, affect autophagy [23] [24] [25] [26] [27] FIG. 1a) . NADPH oxidase and the autophagic machinery are connected via an autophagy regulatory protein known as RUBICON (run domain beclin 1-interacting and cysteine-rich-containing protein), which interacts with beclin 1 and the PtdIns 3 kinase catalytic subunit VPS34. By physically disassociating from the autophagy inhibitory complex and associating with the NADPH oxidase activating complex, RUBICON activates two bactericidal mechanisms (that is, autophagy and ROS production), although it is not known whether the activation of these two mechanisms occurs simultaneously 26 . Nitric oxide inhibits autophagy by inactivating Jun N-terminal kinase 1 (JNK1) and IKKβ through direct S-nitrosylation 27 . This prevents JNK1-dependent BCL-2 phosphorylation 27 and BCL-2 dissociation from beclin 1 28, 29 and inhibits IKKβ-associated AMPK-dependent autophagy initiation 27, 30 . also FIG. 3) are shown. Failure to remove SLRs by autophagy can increase the levels of these receptors and the levels of pro-inflammatory signalling. Autophagy can deliver cytoplasmic pathogen-associated molecular patterns (PAMPs) to endocytic TLRs and can stimulate their activity. NOD-like receptors (NLRs; such as NLRP3 (NOD-, LRR-and pyrin domain-containing protein 3)) and RIG-I-like receptors (RLRs; such as absent in melanoma 2 (AIM2)) show complex positive and negative co-regulation with autophagy: the ATG5-ATG12 complex inhibits retinoic acid-inducible gene I (RIG-I) signalling, and autophagy limits inflammasome activation by removing damaged mitochondria, which then release the inflammasome activators reactive oxygen species (ROS) and mitochondrial DNA. c | The role of autophagy in adaptive immunity is shown. Autophagy can increase the MHC class II presentation of cytoplasmic antigens, including self or viral antigens, as well as promoting the citrullination of antigens. LAP can enhance the processing of particulate antigens for MHC class II presentation. NOD2 enhances autophagic antigen presentation. Autophagy may directly or indirectly affect MHC class I presentation by competing with the proteasome for substrates, by influencing the peptidome pools through the control of levels of components of microRNA (miRNA) machinery (for example, argonaute (AGO) and DICER), or by supporting unconventional MHC class I presentation. In addition, autophagy affects the self-renewal of haematopoietic stem cells (HSCs), B1 cell development, plasma cell survival and IgG secretion. Autophagy affects T cell survival following T cell receptor (TCR) activation, and it destabilizes the immunological synapse. It also controls innate immune cell (such as macrophage) signalling through the release of interleukin-1α (IL-1α) and IL-1β, which influence the polarization of T cells into T helper 17 (T H 17) cells. Autophagy also affects naive T cell repertoire selection in the thymus and the survival and function of maturing T cells by removing the mitochondria and endoplasmic reticulum (ER), thus ensuring calcium homeostasis. d | The role of autophagy in the secretion of immune mediators is shown. Autophagy affects the quality of regulated secretion from pre-stored granules. Autophagy affects the quality and the quantity of the output of the constitutive secretory pathway (which is the conventional pathway of protein secretion via the ER, the Golgi apparatus and the plasma membrane). Autophagy supports a form of unconventional secretion that captures cytoplasmic proteins for extracellular release. Note that secretory protein cargo in the regulated and constitutive secretory pathways contains conventional leader peptides for co-translational import into the ER lumen, whereas protein cargo that enters the unconventional secretory pathway lacks leader peptides and does not enter the ER. Dashed arrow indicates that this pathway remains to be defined. DAMPs, damageassociated molecular patterns; HMGB1, high-mobility group box 1 protein; IPS1, IFNβ promoter stimulator protein 1; mtDNA, mitochondrial DNA; mTOR, mammalian target of rapamycin; NOX2, NADPH oxidase 2; PRRs, pattern recognition receptors; ssRNA, single-stranded RNA; TRAF6, TNF receptor-associated factor 6. 
Xenophagy
The selective degradation of intracellular pathogens (such as bacteria or viruses) through macroautophagy.
LC3-associated phagocytosis
(LAP). A shared pathway that involves conventional phagocytosis and autophagy at the maturation stage that is mediated by the recruitment of the autophagy protein LC3 (which is the mammalian homologue of yeast ATG-8). LAP results in a more robust phagolysosome, which can also function as a specialized signalling compartment or an antigen-presentation compartment.
The connections between autophagy and immune signalling seem to be surprisingly complex. From an evolutionary perspective, these connections reflect the integration of autophagy with several immune regulatory systems.
Direct elimination of microorganisms
Autophagy intercepts pathogen invasion. The antimicrobial functions of autophagy provide a series of barriers against invading microorganisms (FIG. 1a) . The first antimicrobial function is xenophagy, which is the uptake of intracellular microorganisms into double-membrane autophagosomes 4 , and the second is LC3-associated phagocytosis (LAP), which involves the engagement of the autophagic machinery while the bacterium is confined in the nascent and presumably intact phagosome 24, 31, 32 
. Finally, a group of autophagic adaptors 33 , known as sequestosome 1-like receptors (SLRs), are involved in eliminating microorganisms from the cytoplasm. SLRs recognize molecular tags (such as ubiquitin, galectin and membrane phospholipid modifications) present on invading microorganisms or on damaged host membranes that are associated with the pathogen and that physically recruit the autophagic machinery [34] [35] [36] [37] [38] ( FIG. 2) . The importance of autophagy in protecting the cytoplasm from microbial invasion is highlighted by the microbial countermeasures and adaptations that have evolved to inhibit, to block specific stages or to commandeer autophagy 39 (see BOX 4 for recently discovered examples).
Box 2 | Parallels between metabolic and immune signalling in autophagy activation
The model (see the figure) proposes that immune and nutritional signals converge to activate a similar cascade. Nutritional triggers, such as starvation, are transduced via mammalian target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK). Starvation inhibits mTOR and activates AMPK, which in turn activates the serine/threonine protein kinase ULK1 to phosphorylate beclin 1 (REF. 140 ), activating molecule in BECN1-regulated autophagy protein 1 (AMBRA1) 10 and TAK1-binding protein 2 (TAB2) 141 . In the resting state, TAB2 and TAB3 bind beclin 1 and repress its activity 30, 140 . TAB2 activates TGFβ-activated kinase 1 (TAK1) 30 to further enhance AMPK activity. AMBRA1 (REF. 10 ), along with beclin 1 (REF. 107 ), recruits TNF receptor-associated factor 6 (TRAF6). TRAF6 functions as an E3 ubiquitin ligase, generating polyubiquitin chains that in turn stabilize and activate ULK1 (REF. 10 ) and beclin 1 (REF. 107 ), and that probably activate the TAB2 and TAB3-TAK1 complexes. Once fully amplified, the concomitant activation of ULK1 and beclin 1 leads to autophagy through both branches of autophagy regulatory kinasesthat is, the protein kinase ULK1 (via AMPK) and the lipid kinase VPS34 (via beclin 1) (not shown) 107 . . TANK-binding kinase 1 (TBK1) also controls autophagy 14, 77 and promotes the elimination of intracellular microorganisms independently of its role in type I interferon (IFN) activation (not shown) 144 . TBK1 controls both the capture of autophagic cargo (for example, microorganisms) via specialized adaptor proteins 14, 35, 36, 45 and the maturation of autophagosomal organelles into degradative compartments 14, 77 . TBK1 may also contribute to autophagosome formation at stages earlier than autophagosome maturation 77 . BCL-2, B cell lymphoma 2; DAPK1, death-associated protein kinase 1; HMGB1, high-mobility group box 1 protein; IL-1β, interleukin-1β; IRGM, immunity-related GTPase family M protein; JNK1, Jun N-terminal kinase 1; NLRP, NOD-, LRR-and pyrin domain-containing protein; NOD2, nucleotide-binding oligomerization domain-containing protein 2; NOX2, NADPH oxidase 2; P, phosphorylation; RAPTOR, regulatory-associated protein of mTOR; RIPK2, receptor-interacting serine/threonine-protein kinase 2; ROS, reactive oxygen species; RUBICON, run domain beclin 1-interacting and cysteine-rich-containing protein; TLR4, Toll-like receptor 4; Ub, ubiquitylation. 
Crohn's disease
A form of chronic inflammatory bowel disease that can affect the entire gastrointestinal tract, but is most common in the terminal ileum. It is characterized by transmural inflammation, strictures and granuloma formation.
To initiate autophagy, mammalian cells detect the presence, location and extent of the cytoplasmic invasion by a pathogen. Conventional PRRs can elicit autophagic responses at different stages of the hostpathogen encounter 40 . First, TLRs and NOD-like receptors (NLRs) detect released microbial products (that is, PAMPs) very early following infection and this stimulates autophagy. Second, autophagy can be initiated during adhesion-and pathogen-induced uptake of bacteria by the host cell, or during active phagocytosis of bacteria by macro phages 31, 41, 42 . Third, at stages after bacterial uptake, autophagy is induced following pathogeninflicted damage to the newly formed parasitophorous vacuoles 35, 36, 38, [43] [44] [45] and on the escape of bacteria into the cytoplasm 34, 46, 47 . Similarly, the initiation of autophagy following virus infection occurs at various stages of the virus life cycle 25, [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] (FIG. 1a) .
TLRs and autophagy cooperate in the response to PAMPs. The early induction of autophagy downstream of TLR stimulation ensures the prompt upregulation of antimicrobial activities, including the upregulation of autophagy systems in advance of microbial invasion 58, 59 ( FIG. 1a) . This and other triggers, such as IFNγ and 1,25-dihydroxyvitamin D3, may promote the expression and the early delivery of antimicrobial peptides to the parasitophorous vacuoles 19, [60] [61] [62] , or they may direct the autophagic response to the points of microbial entry, as occurs during LAP 31 (FIG. 1a) . In addition, autophagic membranes deliver cytoplasmic PAMPs, such as single-stranded viral RNA, to the endosomal lumen where they can make contact with the luminal portion of endosomal TLRs, such as TLR7, to stimulate other responses, including the type I IFN response 50 (FIG. 1b) . Autophagy that is stimulated by TLRs, in conjunction with LAP 53, 63 , enhances antigen presentation by dendritic cells (DCs) (FIG. 1c) . LAP also contributes to the trafficking of TLR9 into specialized IFN signalling compartments in plasmacytoid DCs (pDCs) (FIG. 3) . Thus, TLRs and autophagy influence each other, which amplifies the outputs of both systems in response to microbial invasion.
NLRs interact with ATGs to localize autophagy. The cooperation between NLRs and autophagy in antimicrobial defence is conserved from flies 64 to humans 41, 42 . NOD1 (nucleotide-binding oligomerization domaincontaining protein 1) and NOD2 detect muramyl peptides in the cytoplasm and they direct the autophagic machinery by recruiting ATG16-like 1 (ATG16L1) to the plasma membrane at the site of bacterial entry 41 (FIG. 1a) . The NOD2-assisted localization of ATG16L1 at the plasma membrane is consistent with the role of ATG16L1 in the formation of a portion of autophagic precursors from the plasma membrane 65 
. Of note, polymorphisms at the ATG16L1 and NOD2 loci have been associated with an increased risk of Crohn's disease 66 . Cells from donors who are homozygous for the Crohn's disease risk allele ATG16L1*300T have a decreased capacity for autophagy induction in response to the NOD2 agonist muramyl dipeptide. The truncation of NOD2 that occurs in patients with Crohn's disease renders it cytoplasmic, which results in the retention of ATG16L1 in the cytoplasm. This precludes ATG16L1 recruitment to bacterial entry sites and thereby prevents timely and site-specific control of autophagy.
Other NLRs also interact with the autophagic machinery. NLRX1 and its interacting partner mitochondrial Tu elongation factor (TUFM), which associates with ATG5-ATG12 complexes and with ATG16L1, promote autophagy 67 (FIG. 3b) . NLRC4 (NOD-, LRR-and CARDcontaining protein 4), NLRP3 (NOD-, LRR-and pyrin domain-containing protein 3), NLRP4 and NLRP10 interact with beclin 1 (REF. 68) 
. The recruitment of NLPR4 to the plasma membrane during the phagocytosis of group A streptococci leads to its transient dissociation from beclin 1. This enables the initiation of beclin 1-mediated autophagic responses 68 . Collectively, NLRs may gather autophagy factors in the vicinity of the incoming microorganism (or resident mitochondria), which leads to the activation of autophagy.
Nucleic acid sensors and autophagy. RIG-I-like receptors (RLRs), including retinoic acid-inducible gene I (RIG-I), melanoma differentiation-associated protein 5 (MDA5; also known as IFIH1) and LGP2 (also known as DHX58), recognize viral RNA to induce the production of type I IFNs and other pro-inflammatory cytokines. Unlike other PRRs, RLRs seem to negatively regulate autophagy 67, 69 . However, downstream molecules that are engaged by RLRs may have an RLR-independent (and possibly competing) function in the induction of autophagy; for example, downstream of nucleic acid sensing by RLRs, the cytoplasmic adaptor protein stimulator of IFN genes protein (STING) activates TANK-binding kinase 1 (TBK1) signalling and type I IFN production, but can also induce autophagy, possibly by the direct recognition of DNA or second messengers that are associated with the presence of cytoplasmic DNA. Indeed, infection with double-stranded DNA viruses, such as herpes simplex virus 1 (HSV1) or human cytomegalovirus, induces autophagy that is dependent on STING 70, 71 . Similarly, bacterial DNA that is released during infection Box 3 | LAP: a shared maturation step for autophagy and phagocytosis Autophagy is often morphologically defined by the formation of double-membrane autophagosomes in the cytoplasm. This is the geometrical consequence of the formation of a phagosome that is derived from a pre-existing membranous intracellular compartment, such as the endoplasmic reticulum (ER), rather than the consequence of a functional requirement for a double membrane. An exception to this rule is the formation of standard phagolysosomes by the autophagy-related protein (ATG) LC3, through a process known as LC3-associated phagocytosis (LAP) 24, 31, 32, 53 . LAP occurs following the uptake of various extracellular targets: particles coated with Toll-like receptor (TLR) agonists, phagocytosed dead cells, live epithelial cells that are engulfed via entosis by neighbouring cells, and the Fcγ receptor-dependent uptake of immune complexes. When a microorganism or a TLR ligand is taken up by conventional phagocytosis 31, 53 , the autophagic machinery enhances the maturation of the conventional phagosomes through the same maturation pathway that is used in internally formed autophagosomes. Thus, LAP uses beclin 1-VPS34 complexes and LC3 conjugation systems. LAP is independent of the serine/threonine protein kinase ULK1 (REF. 32 ) -ULK1 is only required to generate autophagosomes from internal ER membranes during starvation. (FIG. 3e) . Such bacterial DNA can escape from M. tuberculosis-containing phagosomes through pores that are introduced by the bacterial secretion system ESX1 (REF. 45 ). It has recently become evident that, in response to cytoplasmic DNA, host cell systems generate a second messenger, cyclic GMP-AMP (cGAMP) 72 (FIG. 3e) . This cyclic dinucleotide is generated by host cGAMP synthase and activates the type I IFN pathway via STING 72 . It remains to be shown whether cGAMP production in response to bacterial and of an SLR binds to autophagy-related LC3 proteins through its consensus sequence at amino acids 332-342 in sequestosome 1 (also known as p62). The conserved residues are shown. X/(D,E,S,T) indicates that any amino acid (X) is allowed but that acidic (D,E) or phosphorylatable amino acids (S,T) are often present (usually at least one or more within the entire consensus sequence). The core LIR motif residues are aromatic pocket-filling W (or F or Y) residues and aliphatic pocket-filling L (or I or V). They form an intermolecular parallel β-sheet with LC3 proteins or γ-aminobutyric acid receptor-associated proteins (GABARAPs). The CLIR motif, which is a LIR motif that is specific for LC3C, lacks the aromatic residue found in the LIR motif and, instead, uses hydrophobic contacts provided by additional aliphatic residues located between the W and L position anchors to stabilize interactions with LC3C. All human SLRs also contain a ubiquitin-binding domain (UBD): UBA (as found in sequestosome 1 and NBR1) is a three-helix bundle UBD that has affinity for monoubiquitin and K63 ubiquitin linkages; UBAN (as found in optineurin) is a parallel coiled-coiled dimer UBD that has specificity for linear ubiquitin chains; and UBZ (as found in nuclear dot protein 52 (NDP52)) is a zinc finger ββα-fold UBD that binds to monoubiquitin and polyubiquitin. b | A model of cooperative action between different SLRs and E3 ligases in bacterial targeting for xenophagy is shown. The schematic shows a parasitophorous vacuole with glycosylated molecules (in this case β-galactosides) facing the lumen of the vacuole that contains a bacterium and that is experiencing membrane damage. This membrane tear exposes β-galactosides to galectins (for example, galectin 8) which in turn bind to the galectin-interacting region (GIR) motif of NDP52. NDP52 also directly interacts with the E3 ligase LRSAM1 and indirectly with the serine/threonine protein kinase TANK-binding kinase 1 (TBK1), which interacts with optineurin. The CLIR motif of NDP52 binds to LC3C, which is a proposed initiator in the LC3 and GABARAP cascade during bacterial xenophagy. LRSAM1 or other E3 ubiquitin ligases polymerize ubiquitin at molecular targets that are yet to be identified. The hypothetical model includes the putative recognition of bacterial pathogen-associated molecular patterns (PAMPs) by LRSAM1 through its leucine-rich repeat domain. Ubiquitin tags are recognized by UBDs of NDP52, optineurin and sequestosome 1. The LIR motif of optineurin is phosphorylated by TBK1 and this improves LC3 and GABARAP binding. The UBA of sequestosome 1 is also phosphorylated by TBK1 and this improves ubiquitin chain binding. As a consequence, the autophagic isolation membrane initiates at the appropriate location and grows to capture the bacterium and to eliminate it through autophagy. CC, coiled-coil domain; FW, four W domain (also known as the NBR1 domain); KIR, KEAP1 interacting region; NES, nuclear export signal; NLS, nuclear localization signal; P, phosphorylation; PB1, protein-binding domain 1; SKICH, skeletal muscle and kidney enriched inositol phosphatase carboxyl homology domain; TAX1BP1, TAX1-binding protein 1; Ub, ubiquitylation; ZnF, zinc finger domain; ZZ, ZZ-type ZnF domain.
Ubiquitin-binding domains
(UBDs). Domains that have different specificities for ubiquitin chains: UBA, which is found in sequestosome 1, favours K63 polyubiquitin chains; UBZ, which is found in nuclear dot protein 52 (NDP52), binds to monoubiquitin and polyubiquitin; and UBAN, which is found in optineurin, has specificity for linear ubiquitin chains. 
LC3-interacting region motif

CLIR motif
A variant of the LC3-interacting region (LIR) motif (L-V-V), which is found in nuclear dot protein 52 (NDP52). The CLIR motif binds to the LIR-interacting region in LC3C. The CLIR motif lacks the signature aromatic residue of the LIR motif. Instead, it makes compensatory hydrophobic contacts with LC3C.
host-derived cytoplasmic DNA can induce autophagy. Analogous cyclic dinucleotides that are secreted by bacteria (for example, cyclic di-GMP or di-AMP) bind to STING and can activate autophagy when they are introduced into the host cell cytoplasm 45 (FIG. 3e) .
In conclusion, conventional PRRs recognize microbial products at different stages of an infection and initiate an autophagic response that contributes to the efficient elimination of the invading microorganism. However, in some instances, autophagy can suppress type I IFN responses, notably by inhibiting RLR signalling 67, 69 . This relationship paradoxically promotes viral replication, and may explain why autophagy can have a pro-infective role.
SLRs clear microorganisms from the cytoplasm. If a pathogen escapes the autophagy barriers that are controlled by conventional PRRs, it can still be captured in the cytoplasm or even in the cytosol. The autophagy-mediated elimination of cytoplasmic pathogens depends on specialized adaptors known as SLRs 20, [34] [35] [36] 46, 73, 74 (FIG. 2a) . SLRs, which are named after the archetypical protein sequestosome 1 (also known as p62) include sequestosome 1 (REF. 75 ), NBR1 (REF. 76 ), optineurin 36 , nuclear dot protein 52 (NDP52; also known as CALCOCO2; it is full size in humans but truncated in mice) 35 and an NDP52-like receptor TAX1-binding protein 1 (TAX1BP1; also known as CALCOCO3) 77 (FIG. 2a) . SLRs have been shown to affect inflammation in several ways 34, 74, 78 and, as they can be consumed during autophagy 33 , it is possible that SLR accumulation (following autophagy inhibition) or SLR depletion (following autophagy activation) may modulate inflammatory processes (FIG. 1b) .
SLRs contain one or more cargo recognition domains (CRDs) that recognize ubiquitin-tagged 20, [34] [35] [36] 45, 46, 73 or galectin-tagged 38,79 microbial or microorganismassociated targets. Ubiquitin-binding domains (UBDs) that are specific for different ubiquitin chains (UBA, UBZ or UBAN) 80 are present in all known SLRs. SLR CRDs that recognize tags other than ubiquitin include a hook-like CRD (which is the galectin-interacting region (GIR) motif) that enables NDP52 to interact with galectin 8 (REF. 79) (FIG. 2a) . Galectin 8 links NDP52 to cytoplasmically exposed β-galactoside glycans on pathogen-damaged host membranes 38 (FIG. 2b) .
Moreover, all SLRs have an LC3-interacting region motif (LIR motif), which is X/(D,E,S,T)-X/(D,E,S,T)-X/ (D,E,S,T)-W/F/Y-X/(D,E,S,T)-X-L/I/V, where X/ (D,E,S,T) indicates that any amino acid (X) is allowed
but that acidic (D,E) or phosphorylatable amino acids (S,T) are often present (at least one or more within the entire motif) 33 . A modified LIR, known as a CLIR motif (L-V-V) has been identified in NDP52 (REF. 81 ) and possibly in TAX1BP1 (REF. 77) (FIG. 2a) . Phosphorylation of the LIR motif and of the CRDs of SLRs modulates their autophagic activities 14, 36, 82 (FIG. 2b) . The number of SLRs and the type of unique or repetitive structures that are recognized as tags may increase as more research is carried out.
The process of autophagic clearance of microorganisms from the cytoplasm involves the sensing of DAMPs and PAMPs, and often the function of multiple SLRs. An example of autophagy-inducing DAMPs are the glycans that become exposed following damage to host membranes, as in the case of infection with Salmonella spp. 38, 79 .
Box 4 | Microbial countermeasures against autophagy
Microorganisms use a wide range of mechanisms to prevent, to counteract or to commandeer autophagy 39 . These inhibitory mechanisms involve the targeting of beclin 1 (REFS 49, 145) , the inhibition of autophagosomal maturation 51, 57 , the perforation of autophagosomal membranes to prevent acidification 44 , the proteolytic cleavage of autophagy-related protein 8 (ATG8) to irreversibly remove carboxy-terminal lipid modifications 146 , and the masking of epitopes or tags that are recognized by sequestosome 1-like receptors (SLRs) 46, 147 . Autophagy may even be activated to generate nutrients for invading microorganisms 148 . With regard to bacteria, Listeria spp. proteins AktA 46 and InlK 147 interfere with recognition via host ubiquitin tags, and Shigella spp. protein IcsB masks bacterial epitopes 149 , which are recognized by the autophagic machinery, either directly or by recruiting cytoplasmic proteins. The Salmonella spp. deubiquitinase SseL removes ubiquitin tags 88 . The Legionella spp. effector protein RavZ is injected into the host cytoplasm through the bacterial type IV secretion system and inhibits autophagy through irreversible deconjugation of mammalian homologues of ATG-8. This involves the proteolysis of the C-terminal glycine in ATG-8 homologues, which prevents future phosphatidylethanolamine modification 146 . Listeria spp. block autophagosome acidification through the pore-forming toxin listeriolysin O 44 . Bacterial actin-based intracytoplasmic motility may be another factor in evading capture by autophagosomes. This is supported by the role of septin scaffolds in enabling autophagy of cytoplasmic Shigella spp. as they start to polymerize actin 20 . Viruses also interfere with autophagy; for example, herpes simplex virus 1 infected cell protein 34.5 (ICP34.5) 49 , influenza virus M2 protein 52 and HIV protein Nef 51, 57 , all target beclin 1 to either completely block autophagy or to inhibit autophagosomal maturation. Nef binds to the evolutionarily conserved domain of beclin 1 at the same region as the endogenous inhibitor GAPR1 (Golgi-associated plant pathogenesis-related protein 1) 57 . Mouse herpesvirus 68-encoded protein M11 (which is the viral homologue of B cell lymphoma 2) inhibits beclin 1 through its BH3 domain 145 , whereas Kaposi sarcoma-associated virus (KSHV) FLICE-like inhibitory protein (FLIP) blocks ATG3 in the LC3 lipidation cascade 127 . HIV Nef, hepatitis C virus NS3 and measles virus Mev3 interact with autophagy factor immunity-related GTPase family M protein (IRGM), which has consequences that are yet to be fully understood 150 . Finally, several microorganisms can harness autophagy for their own benefit, including using autophagy for replication 39 ; for example, the obligatory intracellular pathogen Anaplasma phagocytophilum uses its type IV secretion effector Ats1 to activate autophagy to supply nutrients 148 . Nature Reviews | Immunology 83 . Following auto-ubiquitylation, LRSAM1 ubiquitylates microbial targets that are yet to be defined and possibly host molecules that are associated with microorganisms. Any of these ubiquitin tags alone or in combination may lead to the recruitment of SLRs through their UBDs (FIG. 2b) .
There is further cooperation (FIG. 2b) between the recognition of the initial tears in microorganismharbouring vacuoles and ubiquitylation, as exemplified in the case of Salmonella spp. infection. In this example, LRSAM1 directly interacts with NDP52 (REF. 83 ). In human cells, NDP52 seems to function as an important hub, as it can recognize LRSAM1 (REF. 83 ), galectin 8 bound to β-galactoside glycans 38, 79 , ubiquitin tags 35 and LC3C (also known as MAP1LC3C), which is required for the acquisition of other LC3 proteins to mediate autophagy 81 . The action of NDP52 is non-redundantly reinforced by other SLRs that may be recruited to Salmonella spp., such as optineurin (which localizes with , which is a binding partner and a negative regulator of beclin 1, inhibits CARD9, whereas sequestosome 1 leads to the degradation of BCL-10. d | Excessive production of reactive oxygen species (ROS) by depolarized mitochondria that are not cleared by autophagy enhance RLR signalling. e | Viral, mitochondrial or bacterial DNA lead to the activation of stimulator of IFN genes protein (STING), probably through cGAMP synthase and cyclic GMP-AMP (cGAMP) production, which increases the type I IFN response. Autophagy removes sources of agonists that stimulate STING, whereas autophagic factors (for example, ATG9) inhibit the activation of STING by affecting its cytoplasmic translocation. Bacterial cyclic dinucleotides (di-AMP and di-GMP) can activate autophagy, thereby functioning as a regulatory loop that amplifies the removal of infectious or endogenous irritants. BCR, B cell receptor; IL, interleukin; LAP, LC3-associated phagocytosis; NK-κB, nuclear factor-κB; TBK1, TANK-binding kinase 1; Ub, ubiquitylation.
Mitophagy
A special form of autophagy by which mitochondria (in a damaged or depolarized state) are engulfed by autophagosomes and degraded.
NDP52 in microdomains surrounding Salmonella spp.) and sequestosome 1 (REF. 36 ). These SLRs bind to ubiquitin through their UBDs that have varied specificities for ubiquitin chains 80 , and, through their LIR motifs, they recruit the remaining LC3 proteins and GABARAPs to mediate autophagosome formation. The affinity of SLRs for LC3 and ubiquitin is further enhanced by phosphorylation of the LIR motif in optineurin and the UBD in sequestosome 1 by TBK1 (FIG. 2b) . TBK1 is recruited to these sites via protein complexes containing NDP52 (REF. 35 ), optineurin 36 and RAB8B 14 , which is a small GTPase that regulates membrane trafficking. The cargo capture and autophagy is coordinated with maturation into autolysosomes by RAB8B 14 . Notably, the NDP52 product that is encoded by the corresponding mouse gene Calcoco2 is carboxy-terminally truncated (and lacks motifs for ubiquitin and galectin binding) (FIG. 2a) and may be primarily expressed in embryonic tissues (see the expressed sequence tags NCBI database). This suggests that, in mice, the function of CALCOCO2 may be primarily conferred through the recruitment of LRSAM1, TBK1 and LC3, as the binding sites for these proteins are retained in the truncated mouse protein. Alternatively, NDP52 activities in mice may be compensated for by the NDP52-like receptor CALCOCO3.
Other pathways to target cytoplasmic microorganisms for autophagy. Autophagy-associated factors have been shown to directly target microbial proteins 47 ; for example, ATG5 binds directly to a Shigella spp. surface protein, VirG. The ATG5-VirG interaction only occurs when the VirG recognition epitope is not masked by another Shigella spp. protein, IcsB
, and requires the ATG5-binding partner TECPR1 (tectonin β-propeller repeat-containing protein 1) which interacts with WIPI2 (WD repeat domain phosphoinositide-interacting protein 2) 47 . WIPI2 is one of the four mammalian PtdIns 3 P-binding ATG18 paralogues and has a role in phagophore formation
. Of note, the control of icsB-mutant Shigella spp. also requires NOD1 activity to induce autophagy and to limit intracellular growth 41 . Moreover, these mechanisms against Shigella spp. are further complemented by ubiquitylation and SLR activity 20, 34 . Taken together, these findings support the idea that autophagic defences are multilayered and cooperative in nature.
Other antibacterial pathways include the autophagy factors beclin 1 (REF. 84 ) and immunity-related GTPase family M protein (IRGM) which directly bind to cardiolipin, a lipid that is only present in bacteria and mitochondria 17 . IRGM is necessary for the optimal induction of autophagy 17 , is partially localized in mitochondria (hence its affinity for cardiolipin) 17 and is a genetic predisposition factor for Crohn's disease 66, 85, 86 . The E3 ubiquitin-protein ligase SMURF1 is required for antiviral responses to Sindbis virus and to HSV1 (REF. 87 ).
SMURF1 is involved in mitophagy
87
, which in some respects resembles bacterial xenophagy. Surprisingly, the HECT (homologous to the E6-AP C terminus) domain of SMURF1 (and hence the region that has its E3 ligase activity) is dispensable for mitophagy and, instead, its phospholipid-binding domain C2 is required. In keeping with the idea that membrane phospholipids or their derivatives are potential tags or signalling intermediates, diacylglycerol has also been implicated in bacterial autophagy 37 . Thus, the presence of an E3 ligase domain in an autophagy-targeting factor does not necessarily indicate that it ubiquitylates the cargo as a requirement for selective autophagy.
In summary, we now understand in greater detail how autophagy is activated in response to microbial presence. Autophagy is controlled by nearly all classes of PRRs and is also regulated by cytokines and receptors that modulate innate and adaptive immunity. Integration of the immune triggers is an obvious area for continuing study, and it is already clear that the antimicrobial functions of autophagy can be promoted (for example, by T H 1 cell-associated cytokines and IL-1β) or inhibited (for example, by T H 2 cell-associated cytokines) by immune mediators. At the intracellular level, an idea has emerged of a graded, multitiered system of autophagic responses that are commensurate with the extent of microbial penetration. An interesting recent development was the discovery of the hierarchical cooperation of several proteins in controlling antimicrobial autophagy. However, gaps in our knowledge remain, especially with regard to alternative, that is, not ubiquitin-based, modes of target recognition. At present, recognition of ubiquitin tags seems to be crucial for autophagy, and this is further supported by evidence of bacterial countermeasures that involve deubiquitylation 88 . Moreover, ubiquitin tags might only activate autophagy after more specialized mechanisms of recognition have failed. It remains to be determined whether overly strong activation of antimicrobial autophagy comes at a price, as exemplified by its interference with type I IFN signalling. Finally, although autophagy is a mode of self defence that is available, in principle, to any eukaryotic cell, the magnitude of its contribution in complex organisms is cell type dependent, as shown by the fact that it has an important role in protecting neurons against HSV1 infection whereas it is absent in keratinocytes of the vaginal mucosa 56 . Thus, at the organismal level, tissue-and cell-specific engagement of antimicrobial autophagy may be a key factor.
Control of inflammation
Genetic links with immune disorders. The role of autophagy in inflammatory diseases was initially established through genome-wide association studies (GWASs) 66 . Polymorphisms in autophagy-associated genes, such as ATG16L1 and IRGM, are linked to Crohn's disease 66 . In addition to single nucleotide polymorphisms, IRGM is an example of a gene dosage (through copy number variants) correlation with a predisposition to Crohn's disease in human populations 85 . One of the common IRGM polymorphisms in Crohn's disease leads to an escape from the negative regulation of IRGM expression by a microRNA (miRNA) 86 . A recent GWAS analysis of 75,000 individuals indicates an overlap between susceptibility loci for inflammatory bowel disease and mycobacterial infections 89 . Moreover, a link has been reported between Crohn's disease and the autophagy-targeting factor SMURF1 (REF. 89 ). Furthermore, polymorphisms in ULK1 have also been linked with Crohn's disease 90 . In addition, polymorphisms in autophagy-associated genes have been associated with autoimmune disorders. IRGM polymorphisms may be a risk factor in systemic lupus erythematosus (SLE) 91 . Moreover, GWASs have linked ATG5 variants with SLE 92-94 and asthma 95 . Rheumatoid arthritis has been associated with variations in the PR domain-containing gene 1 (PRDM1)-ATG5 intergenic region 96 . A new human autophagy locus, which was first functionally identified in Caenorhabditis elegans screens as epg5 and which was shown in mice to be required for autophagosomal maturation 97 , has been linked to the complex Vici syndrome that includes immunodeficiency 98 . Thus, autophagy shows clinical relevance as a result of genetic links with immunological and inflammatory disorders.
Autophagy affects PRR-mediated type I IFN signalling.
The autophagic machinery can amplify TLR signalling; for example, autophagy enhances the delivery of cytoplasmic PAMPs to endosomal TLR7, which enables the recognition of cytoplasmic viral replication intermediates and IFNα production by pDCs 50 . However, the role of autophagy in PAMP-PRR amplification loops can lead to aberrations and auto immunity. In the case of TLR9, which normally responds to microbial unmethylated CpG DNA, the autophagic machinery can enhance aberrant self DNA reactivity. This occurs via intracellular trafficking events following B cell receptor (BCR) stimulation by self DNA-containing antigens 11 . Autophagy promotes the fusion of DNA-containing antigen-loaded BCR compartments and TLR9-containing endosomes and leads to B cell hyper responsiveness 11 (FIG. 3a) .
Similarly, in pDCs the autophagic machinery enhances the trafficking of particulate self DNA-containing immune complexes and of TLR9 to signallingcompetent compartments, which results in increased IFNα production 32 (FIG. 3a) . It is possible that these aberrant autophagic activities in B cells and pDCs could cooperate and lead to the generation of autoimmune plasma cells (FIG. 3a) .
By contrast, there are examples of autophagy-related factors that directly inhibit the formation or that suppress the activation of pro-inflammatory protein complexes. The ATG5-ATG12 complex negatively regulates RLR signalling by directly binding to the caspase recruitment domains (CARDs) of RIG-I and IFNβ promoter stimulator protein 1 (IPS1; also known as MAVS, VISA or CARDIF; it is a mitochondrial adaptor of RIG-I signalling) 69 (FIG. 3b) . RUBICON inhibits CARD9-BCL-10-MALT1 (mucosa-associated lymphoid tissue lymphoma translocation protein 1) signalling complexes by binding to CARD9, which thereby terminates pro-inflammatory signalling downstream of RIG-I or dectin 1 (REF. 99) (FIG. 3c) . The absence of autophagy amplifies RLR signalling through increased IPS1 levels as a result of an accumulation of mitochondria, and increased pools of depolarized mitochondria in the absence of mitophagy are a source of ROS that also enhance RLR effects 25 (FIG. 3d) . NLRX1 promotes autophagy and inhibits the RLR-dependent induction of type I IFN signalling and inflammation (FIG. 3b) ; indeed, the two processes are reciprocally affected by NLRX1 (REF. 67 ). Finally, ATG9 negatively controls the trafficking of STING and suppresses the activation of TBK1 in type I IFN signalling in response to double-stranded DNA 100 (FIG. 3e) .
Collectively, these phenomena may represent feedback loops by which autophagy downregulates type I IFN responses following a period of productive induction or to increase the threshold for activation of type I IFN signalling. Alternatively, autophagic interference with RLR signalling could reflect competition for limited resources, such as TBK1, that are shared between type I IFN signalling and autophagy pathways 14, 36, 45, 101 . These phenomena, in addition to other factors that are not discussed here, could be an explanation for why autophagy paradoxically enhances the replication of certain viruses.
Autophagy suppresses inflammasome activation. The recognition that autophagy has an anti-inflammatory function stems from the observation that the production of IL-1β and IL-18 is increased in the absence of functional ATG16L1 in a mouse model of Crohn's disease 102 . Inflammasomes are cytoplasmic complexes that respond to PAMPs and DAMPs by inducing the proteolytic processing and secretion of IL-1β and IL-18 (REF. 103 ). An inflammasome consists of pro-caspase 1, the adaptor protein ASC and a sensor protein from the NLR family (such as NLRP1, NLRP3, NLRC4, NLRP6 or NLRP12) or from the PYHIN (pyrin and HIN domain-containing protein) family (which includes absent in melanoma 2 (AIM2) and IFNγ-inducible protein 16 (IFI16)) 103 . Several convergent reports show that autophagy has a negative role in inflammasome activation [104] [105] [106] [107] [108] . Under sterile conditions, autophagy clears the cytoplasm of debris, protein aggregates and defective organelles that can function as endogenous inflammasome agonists. Studies suggest that basal levels of autophagy control the set point for inflammasome activation 104, 105 . If autophagy is blocked, this leads to an accumulation of depolarized mitochondria that leak endogenous inflammasome agonists, such as mitochondrial DNA (which is detected, at least partly, by AIM2) and ROS (which activate the NLRP3 inflammasome) 104, 105 (FIG. 1b) .
During infection, the removal of damaged mitochondria may not be a passive process; for example, during infection with influenza A virus, a NOD2-receptorinteracting serine/threonine protein kinase 2 (RIPK2) pathway activates the autophagy factor ULK1 to maintain or to increase mitophagy and to thereby reduce inflammasome activation 108 . This RIPK2-dependent regulation of autophagy may complement the RIPK2-independent action of NOD2 following the recruitment of ATG16L1 to microorganisms 41 and both processes may contribute to inflammatory syndromes such as Crohn's disease. Importantly, autophagy may downregulate prolonged inflammasome activity by removing aggregated inflammasome components 107 . This depends on the recruitment of sequestosome 1 to
Exocyst
An evolutionarily conserved protein complex that consists of eight subunits and that is best known for targeting exocytic vesicles to sites of docking and fusion at the plasma membrane. It also functions as a protein complex assembly platform.
K63-ubiquitylated ASC 107 . A role for exocyst has been implicated in the overall process 107 , but the process could be self-starting, as sequestosome 1 associates with the E3 ligase TRAF6 (REF. 78 ) that ubiquitylates beclin 1 to initiate autophagy 9 ; however, this has not been investigated. In summary, basal autophagy protects cells from inadvertent inflammasome activation initiating damaging sterile inflammation, whereas a deficiency in autophagy causes increased IL-1β levels (FIG. 1b) .
Autophagy suppresses calpain-dependent IL-1α activation. Similarly to IL-1β, IL-1α is synthesized as a cytoplasmic pro-form, and is processed by calpain or other proteases before being actively secreted from cells or passively released following cell death 109 . The activation and the secretion of IL-1α involve caspase 1-dependent and caspase 1-independent processes 109 . Autophagydefective (Atg5 fl/fl LysM-Cre + ) macrophages secrete high levels of IL-1α through a calpain-dependent but inflammasome-independent pathway 109 . This phenotype has been observed both in vitro and in vivo 45, 109 . The processing of pro-IL-1α by calpain is induced by ROS that have been released from accumulated depolarized mitochondria in autophagy-deficient cells 109 . Thus, ROS in autophagy-defective cells activate both the inflammasome and the calpain pathways that lead to the excess production of IL-1β and IL-1α, respectively 104, 109 . IL-1α that has been released from ATG5-defective macrophages has important consequences in vivo, as it leads to enhanced and prolonged T H 17 cell responses in the context of M. tuberculosis infection, which contributes to lung tissue damage in a mouse model of tuberculosis 109 .
Autophagy and degradation of pro-inflammatory signalling factors. Autophagy factors inhibit BCL-10-containing complexes 99 , and autophagy degrades BCL-10 to reduce nuclear factor-κB (NF-κB) activation, as shown in antigen-activated T cells 110 . This occurs via sequestosome 1 association with K63-polyubiquitylated BCL-10 (FIG. 3c) . As mentioned above, BCL-10-containing complexes are also inhibited by the binding of RUBICON to CARD9 (REF. 99 ). As RUBICON is a negative regulator of autophagy, its translocation to BCL-10 complexes leads to the direct inhibition of CARD9-BCL-10-MALT1 signalling and may also enhance the autophagic degradation of these complexes (FIG. 3c) . NF-κB signalling may also be downregulated by autophagy via NSFL1C cofactor p47, which is a protein that has a ubiquitinbinding UBA domain and its orthologue in yeast binds to ATG-8. This potential adaptor functions as a negative regulator of IKK through the lysosomal (and presumably autophagic) degradation of polyubiquitylated NF-κB essential modulator (NEMO) 111 . The targeting of NEMO for autophagic degradation is specifically induced by the murine cytomegalo virus protein M45; this suppresses antiviral processes during infection 112 . In summary, genetic and functional studies indicate that autophagy is an anti-inflammatory mechanism that affects numerous pathways. The most prominent examples are the dampening of inflammasome activation and type I IFN signalling; however, broader targeting of other inflammatory signalling pathways is also becoming apparent. This is consistent with the idea that autophagy eliminates microorganisms (and microbial products or corpses -an area that deserves more investigation) and endogenous irritants to prevent excessive inflammation. When autophagic clearance fails, inflammation ensues as the body's response to persistent danger. This may be an explanation for the selection of genetic alleles in autophagy-related factors that promote inflammation at certain anatomical sites. This has been recently shown in the case of the Crohn's disease risk factor ATG16L1, whereby a defect in autophagy may paradoxically confer protection against uropathogenic Escherichia coli (UPEC) by increasing the production of pro-inflammatory cytokines and by promoting the recruitment of innate immune cells to UPEC-infected bladders in ATG16L1-hypomorphic mice 113 .
Autophagy in adaptive immunity
Autophagy in antigen presentation and T cell responses. Autophagy functions as a bulk 'topological inverter' by transporting proteins from the cytoplasm into the lumen of antigen-processing compartments 54, 114, 115 (FIG. 1c) . This property can be artificially exploited by fusing antigens (such as influenza virus matrix protein 1) to LC3 to enhance MHC class II-mediated antigen presentation to CD4 + T cells 116 . The topological inversion principle is more generally applicable as it supplies cytoplasmic ligands to endosomal receptors; for example, autophagy transfers viral RNA replication intermediates to lumenal TLR7, as discussed above.
The contributions of autophagy to MHC class II presentation are not restricted to cytoplasmic proteins and extend through LAP to exogenous antigens. Autophagy augments the MHC class II-dependent processing and presentation of phagocytosed extracellular particulate antigens, as shown using PRR-stimulated LAP of ovalbumin-coated latex beads in DCs 53 . PRRmediated enhancement of MHC class II presentation also occurs through the induction of autophagy following NOD2 stimulation with bacterial muramyl dipeptides 42 (FIG. 1c) .
Autophagy-enhanced MHC class II presentation possibly has a role in the selection of naive T cell repertoires in the thymus. In autophagy-deficient mice, both positive and negative selection of CD4 + T cells but not of CD8 + T cells were affected, and this had consequences for the selection of appropriate T cell receptor (TCR) repertoires and for the elimination of autoreactive CD4 + T cells 115 . Transplantation of ATG5-deficient thymi into wild-type mice caused an infiltration of autoreactive CD4 + T cells into multiple organs and induced autoimmune colitis that was similar to Crohn's disease-related phenotypes 115 . These effects have been attributed to the defective presentation of cytoplasmic antigens by autophagy-deficient thymic epithelial cells 115 . Other studies investigating DC function indicate that autophagy-dependent antigen presentation is defective in DCs from patients with Crohn's disease that express the ATG16L1 or NOD2 disease risk variants 42 . , autophagy promotes the presentation of citrullinated antigens that may be relevant to autoreactivity (FIG. 1c) . This process is constitutive in DCs and macrophages, but in B cells it only occurs following BCR stimulation 117 . In contrast to this augmentation of MHC class II antigen processing by autophagy, autophagic degradation promotes the disassembly of immunological synapses 118 . Inhibition of ATG16L1 and IRGM expression in DCs leads to hyperstable interactions with T cells and increases T cell activation 118 . This activation might be further enhanced in the T cells by the lack of autophagic degradation of BCL-10 (REF. 110) (FIG. 3c) . Therefore, although autophagy initially promotes MHC class II antigen processing, at later stages it may help to downregulate the response. Consistent with this idea, during cancer cell invasion the epithelial-to-mesenchymal transition is associated with an attenuation of immunological synapses between target cells and cytotoxic lymphocytes in a process that is dependent on autophagy and beclin 1 (REF. 119 ).
Autophagy affects conventional MHC class I presentation by competing with the proteasome for the degradation of newly synthesized cytoplasmic proteins 120 (FIG. 1c) . Autophagy may also contribute to unconventional MHC class I presentation pathways in ways that are yet to be fully understood 121, 122 . In principle, autophagy could broadly affect MHC class I peptide repertoires; for example, NDP52-dependent autophagy targets DICER and argonaute (AGO) 123 , which are involved in miRNA processing and function. This might correlate with the abundance of MHC class I-associated peptides that seem to be derived from transcripts containing miRNA response elements (FIG. 1c) .
Autophagy in T cell homeostasis and T H 17 cell polarization. In addition to its role in antigen presentation, autophagy affects both the homeostasis and the function of T cells (FIG. 1c) . Autophagy and clearance of mitochondria are needed for normal haematopoietic stem cell (HSC) maintenance and function, which are essential for the production of both myeloid and lymphoid progenitor cells 124 . After exiting the thymus, naive T cells depend on autophagy and mitochondrial content reduction for their maturation 125 . T cells require maintenance of an ER that is capable of calcium homeostasis 126 . Calcium ions are sequestered in ER-like structures that accumulate in ATG7-deficient T cells. This curtails calcium fluxes in response to TCR engagement 126 . In naive T cells, autophagy is suppressed by cellular FLICE-like inhibitory protein (CFLIP; also known as CFLAR) 127, 128 , but TCR signalling and CD28 co-stimulation induce autophagy in activated T cells 129 . Autophagy is a pro-survival process in activated T cells and counteracts the pro-apoptotic function of CD95 (also known as FAS) and CD95L (also known as FASL), which are upregulated by TCR stimulation 128 .
Following T cell activation, autophagy can influence T H cell polarization, partly by controlling the inflammatory function of innate immune cells; for example, the excessive secretion of IL-1α and IL-1β from autophagydeficient macrophages, functions together with IL-6 and transforming growth factor-β (TGFβ), to promote T H 17 cell responses 109 (FIG. 1c) . Indeed, the levels of IL-17 are increased in the lungs of mice with ATG5-deficient myeloid cells during M. tuberculosis infection 109 . CD4 + T cells show increased IL-17 expression when lung-infiltrating leukocytes from mice with an ATG5 deletion in the myeloid lineage are restimulated with mycobacterial antigens ex vivo 109 . The increased T H 17 cell response might also result from the increased durability of immunological synapses between T cells and autophagy-defective DCs 109, 118 .
Autophagy in plasma cells and humoral immunity.
Although autophagy seems not to be important for the survival of the majority of mature B cells 130 , lymphoid precursor stages are affected by the absence of autophagy 131 . Autophagy is needed for the survival of B1 cells, which are a subset of self-renewing B cells that cannot be replenished from the adult bone marrow 130 . Moreover, autophagy has a role in ER maintenance in plasma cells under conditions of high secretory demands. Somewhat paradoxically, absence of autophagy leads to excessive immunoglobulin secretion 132 . Autophagy is important not only for the function of plasma cells but also for their survival and homeostasis; it is especially important for the preservation of the bone marrow plasma cell pool and, thus, is relevant for the maintenance of long-lived humoral immunity 132 (FIG. 1c) .
In summary, autophagy influences adaptive immune responses through its effects on antigen presentation, naive T cell repertoire selection, T cell homeostasis and T H cell polarization. Remaining questions include whether autophagy affects T cell polarization beyond T H 17 cell responses -for example, whether it affects regulatory T cells and other T cell subsets -and how autophagy in one cell type affects other cells and immune networks in specific anatomical sites. Answers to these questions should help to explain the complex phenotypes that are associated with risk mutations in autophagy genes.
Secretion of immune mediators
In addition to its intracellular actions, autophagy influences the extracellular release of immune mediators [133] [134] [135] ( FIG. 1d) , some of which are stored as pre-made secretary granules. The defective secretion of lysozyme from Paneth cells in ATG16L1-hypomorphic mice results in an intestinal phenotype that corresponds to that of patients with Crohn's disease 133 . Autophagy modulates the secretion of low-molecular-mass immune mediators such as ATP, which function extracellularly -either directly or following ectonucleotidase action -on purinergic P2Y and P2X receptors to promote immune cell chemotaxis and inflammasome activation 135 . Autophagic processes in senescent cells affect the secretion of IL-6 and IL-8 through the constitutive ER-to-Golgi apparatus secretory pathway 136 . Autophagy reduces immunoglobulin
Citrullinated antigens
Citrullin is enzymatically generated from arginine residues by peptidylarginine deaminase, which is an enzyme that may be enriched in autophagosomes. The presence of autoantibodies in patients with rheumatoid arthritis correlates with the levels of citrullinated antigens (such as vimentin). secretion from plasma cells and, thus, seems to be a mechanism that prevents excessive antibody production 132 . The effects of autophagy on secretory functions are not limited to immune effectors: for example, autophagy factors and LC3 have a role in the exocytosis of secretory lysosomes, as has been observed for a form of LAP during osteoclastic bone resorption 137 . Autophagy may contribute to the unconventional secretion of cytosolic proteins that have extracellular immune functions. The exact mechanism by which this occurs is not fully understood. IL-1β and IL-18 do not have signal peptides that facilitate entry to the ER and the conventional secretory pathway (ER to Golgi apparatus to plasma membrane). Instead, they are delivered following inflammasome activation to the extracellular environment via unconventional secretion. Although autophagy suppresses inflammasome activation under normal nutrient-rich conditions, autophagy can contribute to the unconventional secretion of IL-1β under stress conditions, for example, following nutrient starvation 106 . It is possible that autophagy functions as a double-switch mechanism to repress the inflammasome under basal conditions but to temporarily increase its physiological output in response to DAMPs or PAMPs during infection. The pro-inflammatory role of autophagy also extends to the unconventional secretion of IL-18 and the DAMP HMGB1 (REF. 106 ). This role depends on ATG factors and on a specialized unconventional secretion regulator Golgi reassembly-stacking protein (GRASP; for example GRASP of 55 kDa (GRASP55)). GRASP is important not only in unconventional secretion but also affects canonical starvation-induced autophagy in mammalian cells 106 . Our understanding of the molecular and cellular mechanisms that are involved in the secretory role of autophagy is still in its infancy. It nevertheless extends the idea of the importance of autophagy in the intracellular space to the extracellular milieu, where it affects tissue organization, remodelling and the delivery of extracellular mediators of immunity and inflammation.
Epithelial-to-mesenchymal transition
Conclusions
Autophagy influences many aspects of innate and adaptive immunity. Indeed, it is possible that autophagy evolved as one of the first antimicrobial defences in eukaryotic cells, and that it was shaped early on in evolution from what may initially have arisen as a metabolic and quality control pathway. Autophagy uses a distinct set of adaptors, the SLRs, to eliminate invading microorganisms and, in turn, pathogens have evolved strategies to evade autophagic capture. It seems that as evolution has progressed, nearly all components of the innate immune system, such as conventional PRRs and inflammasomes, have become integrated with autophagy. In the chordate lineage, this has extended to adaptive immunity, as is best shown in mammalian systems. As a result, in humans, a failure in parts of the autophagic apparatus can lead to inflammatory, autoimmune or general immune disorders.
The current knowledge of immunological autophagy is still in its infancy and important questions remain. As IKKs and TBK1 regulate autophagy, why is autophagy often at cross-purposes with type I IFN-mediated inflammation? Is the ubiquitylation of microbial components the main process that leads to pathogen recognition by SLRs, or does it result from a failure to detect microorganisms by other means? How are the recognition of microbial entry and the subsequent targeting of microorganisms for autophagy integrated through the functions of host membrane damage sensing, E3 ubiquitin ligases, and protein and lipid kinases? Are mitochondria and mitophagy the present-day manifestation of an evolutionary battle between autophagy and the bacterium endosymbiont precursor to mitochondria? The increased understanding of the roles of autophagy in secretion during inflammation and tissue remodelling is an important development. In this context, the relationship between autophagy and unconventional secretion, including the secretion of DAMPs and of inflammasome-dependent substrates such as IL-1β, needs further work. Finally, although early progress has been made in understanding the roles of autophagy in adaptive immunity, this area warrants more study. Some of the questions that have recently been asked in this area refer to the role of autophagy in the polarization of T H 17 cells and possibly other T cell subsets, along with the role of autophagy in general lymphocyte homeostasis and differentiation.
In summary, autophagy and immunity are fully integrated and our continuing study of the interface between these processes will be a fruitful area of scientific inquiry for many years to come. In translational terms, autophagy is undoubtedly an attractive target for developing new treatments in inflammatory disorders and autoimmunity, and may eventually be harnessed as an anti-infective mechanism.
